Moderna
MRNA
$107.97
Share price
1.69%
Change (1 day)
-18.75%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: $41.33 Billion
As of April 2024 Moderna has a market cap of $41.33 Billion. This makes Moderna the world's 461th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $41.33 B | 9.02% |
| 2023 | $37.91 B | -45.05% |
| 2022 | $69.00 B | -32.99% |
| 2021 | $102.97 B | 149.1% |
| 2020 | $41.33 B | 528.01% |
| 2019 | $6.58 B | 31.11% |
| 2018 | $5.02 B |
End of Day market cap according to different sources
On Apr 28th, 2024 the market cap of Moderna was reported to be:
$41.33 Billion
$41.33 Billion
$41.25 Billion
$41.33 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.16 B | 751.88% | 🇺🇸 USA |
 Novartis NVS | $200.09 B | 384.03% | 🇨🇭 Switzerland |
 Merck MRK | $332.33 B | 703.91% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $0.15 B | -99.62% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | -92.80% | 🇺🇸 USA |
 Athersys ATHX | $0.83 M | -100.00% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $18.12 B | -56.16% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $2.74 B | -93.37% | 🇺🇸 USA |